Ayala Pharmaceuticals Inc (ADXS)
0.572
0.00 (0.00%)
USD |
OTCM |
Apr 19, 14:09
Ayala Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.00% |
| December 31, 2022 | 0.00% |
| September 30, 2022 | 0.00% |
| June 30, 2022 | 0.00% |
| March 31, 2022 | 19.65% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | -0.81% |
| September 30, 2019 | 42.60% |
| June 30, 2019 | 81.22% |
| March 31, 2019 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-0.81%
Minimum
Dec 2019
81.22%
Maximum
Jun 2019
8.92%
Average
--
Median
Mar 2020
Gross Profit Margin (Quarterly) Benchmarks
| Taro Pharmaceutical Industries Ltd | 50.83% |
| InspireMD Inc | 28.68% |
| BiomX Inc | -- |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -- |